These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1348 related articles for article (PubMed ID: 31812070)
1. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
2. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Aizemaiti R; Wu Z; Tang J; Yan H; Lv X Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814 [TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related]
4. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment. Yu L; Cao S; Li J; Han B; Zhong H; Zhong R Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738 [TBL] [Abstract][Full Text] [Related]
5. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma. Fang L; Yu W; Yu G; Zhong F; Ye B Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis. Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150 [TBL] [Abstract][Full Text] [Related]
7. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma. Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535 [TBL] [Abstract][Full Text] [Related]
8. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma. Guo L; Li X; Liu R; Chen Y; Ren C; Du S Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817 [TBL] [Abstract][Full Text] [Related]
9. DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration. Xu Y; Jiang Q; Liu H; Xiao X; Yang D; Saw PE; Luo B J Immunol Res; 2020; 2020():8835393. PubMed ID: 33490290 [TBL] [Abstract][Full Text] [Related]
11. Seven interferon gamma response genes serve as a prognostic risk signature that correlates with immune infiltration in lung adenocarcinoma. Yao B; Wang L; Wang H; Bao J; Li Q; Yu F; Zhu W; Zhang L; Li W; Gu Z; Fei K; Zhang P; Zhang F; Huang X Aging (Albany NY); 2021 Apr; 13(8):11381-11410. PubMed ID: 33839701 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of the association between tumor-infiltrating immune cells and the prognosis of lung adenocarcinoma. Pan Y; Sha Y; Wang H; Zhuang H; Ren X; Zhu X; Wei X J Cancer Res Ther; 2020; 16(2):320-326. PubMed ID: 32474519 [TBL] [Abstract][Full Text] [Related]
13. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484 [TBL] [Abstract][Full Text] [Related]
14. High TLX1 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Lung Adenocarcinoma. Zhao L; Zheng H; Chen F; Lu H; Yu Q; Yan X; Chen X; Zhang Q; Bu Q Curr Mol Med; 2024; 24(6):801-812. PubMed ID: 37340746 [TBL] [Abstract][Full Text] [Related]
15. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739 [TBL] [Abstract][Full Text] [Related]
16. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
17. NRAS expression is associated with prognosis and tumor immune microenvironment in lung adenocarcinoma. Yan Y; Gao Z; Han H; Zhao Y; Zhang Y; Ma X; Chen H J Cancer Res Clin Oncol; 2022 Mar; 148(3):565-575. PubMed ID: 34746975 [TBL] [Abstract][Full Text] [Related]
18. Establishment and validation of an immune-associated signature in lung adenocarcinoma. Wang Z; Chen X Int Immunopharmacol; 2020 Nov; 88():106867. PubMed ID: 32799112 [TBL] [Abstract][Full Text] [Related]
19. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407 [TBL] [Abstract][Full Text] [Related]
20. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]